Welcome to vnonline.co.uk

vnonline.co.uk provides the veterinary nursing profession with the latest news and industry developments, as well as events, resources, learning materials and careers.

Our website is dedicated to veterinary nurses and we strive to provide a platform where you can voice and explore your interests.

Not a member yet? Sign up for free!

Register for free with vnonline.co.uk to gain unlimited access to news, resources, jobs and much more!



Click here to become a member







Log in to vnonline

Forgot your password?

Posted: 11th February 2021

Vetoquinol acquires Canadian rights to Profender®
"The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment" - Matthieu Frenchin, CEO of Vetoquinol.
Product family encompasses a range of spot-on solutions for cats

Animal health company Vetoquinol has announced the acquisition of the Canadian rights to the Profender® product family from Elanco Animal Health.

The move follows the firm's acquisition of Profender® and Drontal® product families, in relation to Elanco's 2020 acquisition of Bayer Animal Health. In January 2021, Vetoquinol also acquired the Profender® and Drontal® product families in Australia.

Commenting on the acquisition, Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire Profender® for the Canadian market, one of our prominent strategic countries. 

“The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment. Adding this essential to our product portfolio in Canada will strengthen our market share in the pet segment in this strategic country.” 

The Profender® family of products encompasses a range of spot-on solutions for cats.

 




Become a member
or log in to add this story to your CPD history